chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a pharmacist refers to a 62 year old female patient with drug reactions/allergies to NSAIDs (nonsteroidal antiinflammatory drugs) and sulfonamides and hyperlipidemia. On 18-FEB-2013 the patient was vaccinated with ZOSTAVAX (single dose, lotnumber reported as H020844 exp date 02-FEB-2013) subcutaneous in the right upper arm as vaccination. Concomitant therapies included diphenhydramine and unspecified medication for hyperlipidemia. On 18-FEB-2013 the patient experienced redness and swelling at the injection sire after administration of ZOSTAVAX. The patient self-treated at home with BENADRYL. On 19-FEB-2013 the patient felt 'heaviness in her chest and soreness in the back of her neck the day after she received ZOSTAVAX. The patient tool nitroglycerin for these symptoms. No laboratory tests were performed. The outcome of heaviness in her chest, redness and swelling at the injection site and soreness in the back of her neck was reported as recovering. The relatedness for the adverse events was not reported for ZOSTAVAX. The patient sought medical attention, came in to pharmacy. Additional information is not expected.
2 hours after vaccine, felt poorly and blurry vision. Nurse called to home. Blood pressure less than 70/40. Provided supportive care with oral fluids and rest. After 3 hours, all vitals returned to normal and felt "fine" again.
Pt c/o achiness and tender arm as expected after vaccine but vaccine is not approved for patient's under the age of 18.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild
The day after he got his shots he woke at 4:00 am saying, "I feel horrible." He had a headache, dizzyness, and nausea. His temp at 5:00 am was 100.3. We put him on 240 mg Tylenol, and called the doctor later that morning. We were told to watch for a stiff neck, and uncontroled vomitting. Later that day, at 2:30 pm, he vomitted, but then felt much better. By the next day he was feeling fine.
0.25ml Fluvirin given to pt, rec >4 yrs.  Box marked but not an actual vial.  Pt had no reaction.
Ringing in ears after first shot; very bad headache; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in ears after first shot) and HEADACHE (very bad headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported.).   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TINNITUS (Ringing in ears after first shot) and HEADACHE (very bad headache). At the time of the report, TINNITUS (Ringing in ears after first shot) and HEADACHE (very bad headache) outcome was unknown. Not Provided          This case was linked to MOD-2021-047851 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Contact information updated- non-significant followup
achiness; Fatigue; Lost her sense of taste; Headache; This is a spontaneous report from a contactable consumer reporting for his daughter. A female patient of an unspecified age, (reported as "26") received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via an unspecified route of administration, on an unknown date on "Tuesday" as a single dose for COVID-19 IMMUNIZATION. Relevant medical history and concomitant medication were not provided. On an unspecified date, the patient experienced achiness, fatigue, lost her sense of taste and headache. The outcome of the events achiness, fatigue, lost her sense of taste and headache was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
got ill for 2 days after the second  dose of the vaccine; This is a spontaneous report from a Pfizer Sponsored Program, received by a contactable consumer (patient's sister).  A 70-year-old female patient received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date at single dose for COVID-19 immunization. No relevant medical history and concomitant medications were provided. The patient was not sure if it was Pfizer or Moderna. The patient had received the 2 doses of the COVID-19 Vaccine 3 weeks apart. The patient was ill for 2 days after receiving the 2nd dose of the COVID-19 Vaccine, and then was fine. The patient had recovered from the  event on unknown date.  No follow-up attempts are possible. No further information is expected. Information about lot/batch number cannot be obtained.
1.) Mild headache and moderate body aches with low grade fever beginning day of vaccination, dissipating on day 2.  2.) Arm soreness and minor rash at injection site appeared 8 days after vaccine administration, lasted approximately 2 days. 3.) First post-vaccine menstruation was 12 days early and noticably heavier than usual with increased cramping and body aches.
"Patient" got the 4 immunizations listed below on 8/27. on the right arm, the only shot given subq which was a varicella developed an area of erythema which was slightly hard but non tender.
Immediately following the injection, I stood up and a sharp, painful shooting pain shot from my arm across my chest on the left side. I remember saying I don't feel good, then lost consciousness. I have vague recollection of someone slapping my face, yelling I can't get a pulse, get an AED, and I lost consciousness again. When I came to I was surrounded by multiple staff and very disoriented. One nurse apologized to me saying I might have a bruise on my chest because she thumped me when they couldn't get a pulse. I'd never opened my eyes till after that. They called for an ambulance and called my husband who was close by. Paramedics arrived and assessed me ready to take me to the hospital, but I refused just wanting to go home and to bed. I was, and still am, very shaken by the event. Now I don't know what to do about being fully vaccinated. Can I get the Janssen, I asked my rheumatologists and they said absolutely not to the 2nd mRNA and that there's little research about the risk of the JJ as a second. What are people like me to do as we are ostracized from society unable to get a 2nd shot.
Admit 2/19. Vaccinated 1/3, 1/28.  Per notes tested + Jan 2021. Admit for hypoxia and PNA, difficult to determine if COVID related. Treated w.abx. DCd to Rehab.
I felt horrible 16 hrs. after my 2nd dose. I felt like I have Covid, All the same symptoms such as fever 101.4, Chills, fatigue, body aches, and cough. Stats were normal and lasted 28 hours and by afternoon on Friday I was mostly better. I did call out of work on Friday. I had a case of Covid a year later on January 6, 2022 and tested positive for Covid on 01/09/2022 I went for a PCR on the afternoon of the 6th and the PCR was negative and was told I tested too. This time my stats were ok and I was not nearly as sick and the flu like symptoms only lasted 3.5 days But cough and fatigued did linger. On the 9th I did go to Urgent Care, she wanted to send me for monoclonal Antibodies but they had recently changed the criteria - I had met criteria for being overweight and having Hypertension but at that point I was starting to feel better.
Within 24 hours after receiving the vaccine I had fever, chills, fatigue that lasted for about 4-5 days. Also, there was severe soreness in my arm where the shot was given.
Patient received covid vaccine dose 1 with lot number FJ8757 on 1/28/22 and that lot expired on 1/15/2022. Email has been sent to provider to reach out to patient.
Patient cannot feel anything below her waist after the vaccine and cannot walk. This lasted for less than 10 minutes then it went away. Patient is a healthy woman.
uterine infection; arm was a little red and sore; arm was a little red and sore; booster dose; booster dose; This is a spontaneous report from a contactable consumer (patient) via a regulatory authority. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine includes first dose and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on unspecified dates for covid-19 immunization. The patient developed uterine infection on an unspecified date the day after the injection. The patient asked if it was a side effect that has been reported. The patient also reported that her arm was a little red and sore, not bad on an unspecified date. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Widespread vesicles, DX chickenpox , post vaccination , TX Acyclovir.
Moderna COVID-19 Vaccine EUA: patient presents to allergy clinic for long-term follow-up after reaction to immunization. Within five minutes of vaccination reported upper lip swelling and numbness. Received oral diphenhydramine and symptoms resolved. Took another dose of oral diphenhydramine six hours later. Patient woke up with lip swelling and facial numbness, went to the emergency department, received IV diphenhydramine with symptom resolution. Patient continued to take oral diphenhydramine for 24 hours and symptoms did not recur.  Received Janssen COVID-19 vaccine booster shot one month later without reaction.
Patient presented to the vaccination site on 11/07/21. The client notified RN  that she was here two days before her due date for her second dose. Client received first dose of Pfizer COVID vaccine on 4/18 21. Client asked RN  to notify her supervisor about getting vaccine 2 days before her 6 months.  RN  submitted a medical consult via text message to Vaccine Operations Leads, requesting to proceed with the COVID Pfizer booster dose vaccine. Approval to proceed with COVID booster vaccine Pfizer was obtained from medical consult team via text message from  RN, Vaccine Operations Lead . Client received COVID vaccine Pfizer (Lot#FF8839) on 12/26/86. The client did not report any symptoms during the 15 minute observation period. RN  educated client on possible adverse reactions and when to seek medical care. The client left the vaccination site unassisted and with a steady gait at 1200.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. In 2012, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the long-term prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. In 2016, the patient was treated at a doctor's office for the onset of a vesicular rash which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 30-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (1Drink/week). Concomitant products included VITAMIN B6 and MACROGOL 3350 (GAVILAX) for an unknown indication.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. The patient's last menstrual period was on 05-Oct-2020 and the estimated date of delivery was 12-Jul-2021. On 16-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  nineteenth week of the pregnancy.  At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan normal: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (1Drink/week). Concomitant products included VITAMIN B6 and MACROGOL 3350 (GAVILAX) for an unknown indication.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. The patient's last menstrual period was on 05-Oct-2020 and the estimated date of delivery was 12-Jul-2021. On 16-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  nineteenth week of the pregnancy.  At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan normal: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment: No treatment was provided.
C/O soreness at injection site since date of injection. Denies numbness and tingling in left hand has tried heat, ice, TYLENOL & ADVIL. To follow up with PCP.
This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Very warm on arm), BACK PAIN (Painful in her waist to turn over to other side) and FEELING HOT (Whole body felt warm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Seizures.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Very warm on arm), BACK PAIN (Painful in her waist to turn over to other side) and FEELING HOT (Whole body felt warm). At the time of the report, VACCINATION SITE WARMTH (Very warm on arm), BACK PAIN (Painful in her waist to turn over to other side) and FEELING HOT (Whole body felt warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient received unspecified medications for seizures. Treatment details were not reported.
Patient describes pain as severe joint pain and full body aches. Pain began at 3pm on the 29th of January and did not subside until the 31st.
Aching body, chills, rash that lasted 48 hours near armpits and swollen lymph nodes.
Received Prevnar and Fluzone HD 1: apart in the Right Arm - Sunday morning below the area that the injections were given (right above the elbow) she developed a rash and was extremely tired the whole day.  Still present Monday and started taking Benadry which helped a little, now has heat and a bruise forming.
Fever (100.8), chills, headache,  nausea, sore arm at injection site,
Patient stopped by the pharmacy on 05/01/2018 to report the adverse event. She stated she experienced dizziness, body aches, flu symptoms and swelling at the injection site. These symptoms abated after a few days.
I developed a rash a half an hour after, ive continued to have a rash on and off, all over. Mostly on my hands including palms, feet, legs, and neck.
Lost 100% of vision in left eye and 50% of vision in right eye; Numbness of face and neck; Numbness of face and neck; Swelling of face and neck; Swelling of face and neck; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, Manufacturer Pfizer BioNTech, lot number EN6201), via an unspecified route of administration in right arm, on 10Feb2021 at 15:45, at single dose, for COVID-19 immunisation. Medical history included blood cholesterol increased. Patient did not have known allergies, did not have COVID-19 prior to vaccination and was not pregnant at time of events or vaccination. There were no concomitant medications. Patient did not receive other different vaccines in four weeks. Previously the patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer BioNTech, lot# EL3244), in arm left, on 20Jan2021 at 15:45, for COVID-19 immunisation. The patient experienced lost 100% of vision in left eye and 50% of vision in right eye on 10Feb2021 at 17:30 with outcome of recovered on 11Feb2021 at 07:30 (after 14 hours), numbness of face and neck on 10Feb2021 at 17:30 with outcome of recovered on 12Feb2021 at 09:30 (after 40 hours), swelling of face and neck on 10Feb2021 at 17:30 with outcome of recovered on 12Feb2021 at 09:30 (after 40 hours). Patient did not tested positive for COVID-19 after vaccination.  No follow-up attempts are possible. No further information is expected.
After the vaccine I waited 45 minutes to see any reaction, they told me I had no problems, I left. When I got home, I felt very bad chills, fever, muscle and joint pain, pretty bad headache. It lasted for 3 days. I called my doctor and went for a checkup, and she wrote that I needed different tests since I had a history of cancer, so I had a mammogram and came back abnormal. Then, she orders other tests - in process.
Patient falsified DOB when registering for vaccination, stating the minor was 01/24/2005. Guardian, consented to the vaccination. Department of Health verified with statistical records that the patients actual DOB is 01/24/2006 which made the vaccine a contraindication.  No known adverse reactions noted.
Started to feel poorly about 20 hours after the vaccine. Low grade temp of about 99, chills, nausea, arm sore at the injection site, overall fatigue. Symptoms lasted for about 24 hours.
Immediate site reaction large red bands, soreness progressed to pain on movement, touch, limited range of motion progressed to frozen shoulder, bursitis, adhesive capsulitis.
got the Pneumovax vaccine and Prevnar 13 but sometime after that, she got pneumococcal meningitis; got the Pneumovax vaccine and Prevnar 13 but sometime after that, she got pneumococcal meningitis; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (5570). The reporter is the patient.  A female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) (Batch/Lot number: unknown) as dose number unknown, single for immunisation; pneumococcal vaccine polysacch 23v (PNEUMOVAX) (Batch/Lot number: unknown) as dose number unknown, single for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), MENINGITIS PNEUMOCOCCAL (medically significant), outcome "unknown" and all described as "got the Pneumovax vaccine and Prevnar 13 but sometime after that, she got pneumococcal meningitis". Therapeutic measures were taken as a result of drug ineffective, meningitis pneumococcal; patient was given antibiotics (unspecified). Clinical course: It was reported that they were not sure what strain it was because they had started antibiotics right away but they presumed it was one that was not covered by those vaccines which is why her doctor wants her to get the Prevnar 20, however her doctor and the pharmacies do not have it and one of the pharmacies was not even aware it existed.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
under eye swelling; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of EYE SWELLING (under eye swelling) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy. Concomitant products included HYDROCORTISONE for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYE SWELLING (under eye swelling). The patient was treated with HYALURONIC ACID, LIDOCAINE (RESTYLANE L) at a dose of 1 dosage form. At the time of the report, EYE SWELLING (under eye swelling) was resolving. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Other concomitant medications include allergy medications   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: No new information
States started in the evening at 1700 after having received the Covid booster vaccine earlier that day.  Came in to Urgent Care about 22 hours after onset of symptoms.  Had chills, fatigue, difficulty breathing & felt like she could not get air in, nausea/vomiting 3-4 times, feeling weak, sore arm, slight swelling to face.
Weakness, muscle pain, soreness of the left arm, minor nausea and minor upset stomach.
Rash noted to bilateral arms, legs and torso. Solumedrol administered 1 week post onset of rash.  Outcome not available at time of submission.
Vaccinated 3/25/03.  Started feeling poorly on 4/2/03.  Felt warm with neck and shoulder pain.  On Tuesday, 4/3/03 began to feel worse with both sides of neck and Left shoulder pain, lower back pain.  By evening, had fever 103 degrees Farenheit, chills.  Area around vaccination and beyond reddened.  On 4/4, area of redness increased.  Still with neck and shouldler pain.  Seen at Health Department.  B/P 110/70, Pulse 92, respirations 20, Temperature (oral) 100.6.  Examined by Dr.  Keflex 250mg po QID x3 days ordered.  Appointment made to see patient on 4/6/03.  Per Dr., patient with dry cough.  Vaccination site no worse.  Patient feeling somewhat better.  Another four days of Keflex ordered.
Tightness of the heart, difficulty getting enough oxygen, dizziness, weakness, almost passing out. Manual breathing, would stop breathing if stopped thinking about it.  An EKG said heart was fine, and x-ray said lungs were fine. Diagnosed with a particularly strong immune response and given oral steroids which seemed to be effective. Told to go home and rest.